Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Inventory (2023 - 2025)

Bioharvest Sciences has reported Inventory over the past 3 years, most recently at $4.6 million for Q4 2025.

  • For Q4 2025, Inventory rose 24.73% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $4.6 million, up 24.73%, while the annual FY2025 figure was $4.6 million, 24.73% up from the prior year.
  • Inventory was $4.6 million for Q4 2025 at Bioharvest Sciences, up from $4.4 million in the prior quarter.
  • Across five years, Inventory topped out at $4.6 million in Q4 2025 and bottomed at $2.5 million in Q4 2023.
  • The 3-year median for Inventory is $3.7 million (2024), against an average of $3.6 million.
  • The widest YoY moves for Inventory: up 60.71% in 2025, down 9.77% in 2025.
  • Over 3 years, Inventory stood at $2.5 million in 2023, then skyrocketed by 48.22% to $3.7 million in 2024, then grew by 24.73% to $4.6 million in 2025.
  • The last three reported values for Inventory were $4.6 million (Q4 2025), $4.4 million (Q3 2025), and $4.1 million (Q2 2025) per Business Quant data.